Memory-like CD8+ T cells lacking PD-1 adapt to persistent stimulation by reducing TCR signal transduction rather than increasing exhaustion
CD8<sup>+</sup> T cells respond to persistent stimulation during chronic viral infection by stably expressing co-inhibitory receptors and other exhaustion-related molecules. Here we addressed how memory-like CD8<sup>+</sup> T (T<sub>ML</sub>) cells, which sustain the immune response to chronic infection thanks to their stem-like properties, adapt to chronic stimulation when they cannot express the co-inhibitory receptor PD-1. We found an increased initial generation and stable long-term persistence of T<sub>ML</sub> cells lacking PD-1 during chronic viral infection. However, these cells had a reduced ability regenerate upon acute restimulation in the context of a recall response. Mechanistically, the lack of PD-1-mediated inhibition was not compensated by an increased expression of other co-inhibitory receptors or exhaustion related molecules. Rather, the absence of PD-1 resulted in a reduced capacity of the TCR to activate T<sub>ML</sub> cells and to express stemness genes including <i>Myb</i> and <i>Klf4</i>. Similar albeit weaker effects on T<sub>ML</sub> cells were noted when PD-1 engagement was transiently interrupted due to anti-PD-L1 treatment. Thus, stem-like CD8<sup>+</sup> T cells responding to chronic viral infection adapt to the absence of PD-1-dependent co-inhibitory signals by further reducing TCR-mediated activation signaling, likely to prevent excessive or prolonged stimulation of these cells.
Authors
- Catherine Sabatel
- Greta Guarda (ORCID: https://orcid.org/0000-0001-9243-6116)
- Alexandre Dumez (ORCID: https://orcid.org/0000-0002-7123-4336)
- Julia Maier (ORCID: https://orcid.org/0000-0001-9814-523X)
- Romain Veber (ORCID: https://orcid.org/0000-0002-0689-4354)
- Vijaykumar Chennupati (ORCID: https://orcid.org/0000-0003-0014-3274)
- Werner Held (ORCID: https://orcid.org/0000-0003-3292-1536)
- Mélanie Charmoy (ORCID: https://orcid.org/0000-0002-2028-1327)
- Laurie Bonneaux
- Tania Wyss
Institutions
- SIB Swiss Institute of Bioinformatics (CH)
- Università della Svizzera italiana (CH)
- University of Lausanne (CH)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-02-05
- DOI
- https://doi.org/10.3389/fimmu.2026.1743170
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Science Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Université de Lausanne
- Swiss Cancer Research Foundation